Viral Infections & Virology

Explore how the immune system recognizes and responds to viral infections, from innate sensing to adaptive memory. This session covers cytokine signaling, immune evasion tactics, and implications for disease severity. Presentations will include research on T-cell responses, neutralizing antibodies, and immune-based interventions. The track offers valuable insights for vaccine development and immunotherapy.

This session addresses the drivers behind the emergence and resurgence of viral pathogens, including environmental change, globalization, and host adaptation. Discussions will focus on surveillance systems, early outbreak detection, and containment strategies. Real-world case studies will highlight how cross-disciplinary collaboration enhances preparedness. Attendees will examine both known and newly identified viruses posing current health risks.

Gain insights into the development of antiviral compounds, treatment mechanisms, and resistance patterns. Topics will cover small-molecule inhibitors, monoclonal antibodies, and host-directed therapies. Emphasis will be placed on translational research bridging the lab and clinical settings. Sessions will also explore ongoing clinical trials and regulatory considerations for antiviral agents.

Learn about advancements in diagnostic platforms including PCR, CRISPR-based tools, and rapid antigen testing. This track covers the identification of biomarkers for early detection, disease progression, and treatment response. Experts will discuss the integration of diagnostics into outbreak response and patient care. Emphasis will also be placed on improving accuracy, accessibility, and turnaround time.

This session delves into the design, testing, and implementation of viral vaccines, including mRNA, vector-based, and protein subunit platforms. Topics include vaccine efficacy, duration of protection, and addressing global distribution challenges. Presenters will also examine strategies for improving vaccine uptake and addressing public hesitancy. Ongoing trials and emerging technologies will be reviewed.

Understand the complex pathways through which viruses cause disease in humans and animals. This track focuses on cellular damage, inflammation, and virus-mediated immune modulation. Sessions will examine acute and chronic disease models, latency, and viral oncogenesis. Presenters will explore the interplay between viral genetics and host susceptibility in determining disease outcomes.

Explore viruses that cross species barriers or are spread through arthropod vectors such as mosquitoes, ticks, and flies. This session covers spillover events, ecological factors, and surveillance in animal reservoirs. Discussions will highlight prevention strategies, vector control programs, and One Health approaches. Key examples include dengue, Zika, West Nile, and emerging zoonoses.

This track highlights viral infections that disproportionately affect infants and young children. Topics include congenital infections, respiratory viruses, and age-specific immune responses. Experts will discuss diagnostic challenges, treatment protocols, and preventive measures for pediatric populations. Emphasis will be placed on long-term outcomes and vaccine strategies tailored for early life stages.

This session examines how policies and public health systems respond to viral threats at local and international levels. Topics include outbreak preparedness, risk assessment, and communication strategies. Real-world case studies will illustrate lessons learned from recent global health events. Attendees will explore the role of research, data sharing, and policy alignment in improving response effectiveness.

This track explores the biology, replication strategies, and clinical impact of both RNA and DNA viruses. Sessions will highlight differences in mutation rates, genome stability, and replication mechanisms. Topics include retroviruses, herpesviruses, papillomaviruses, and coronaviruses. Researchers will present findings on how viral genome types influence pathogenesis and treatment approaches.

Focuses on the dynamic relationship between viruses and host cells during infection. Discussions include viral entry, cellular signaling manipulation, and apoptosis evasion. This track highlights how viruses hijack host machinery for replication and survival. Understanding these interactions is crucial for identifying novel antiviral targets.

Covers the detection, transmission, and impact of viruses present in environmental reservoirs such as water, soil, and waste. This session addresses viral contamination, surveillance, and disinfection techniques. Case studies will include enteric viruses, norovirus outbreaks, and environmental virology methods. The track emphasizes public health relevance and prevention.

Explores viruses that contribute to cancer development or serve as therapeutic tools against tumors. Topics include HPV, EBV, HBV, and oncolytic virotherapy. Sessions will examine molecular mechanisms of viral oncogenesis and tumor-selective viral replication. Attendees will learn about current strategies in viral-based cancer therapies.

Discusses how viruses evolve under selective pressures, including host immunity and antiviral treatments. Topics cover genetic drift, recombination, and host-jumping events. This track explores how viral evolution shapes transmission dynamics and disease emergence. Case examples include influenza and SARS-CoV-2.

Highlights the use of synthetic biology tools to design viral vectors, study gene functions, and develop therapeutics. Sessions will focus on genome editing, virus-like particles, and synthetic vaccine platforms. The track offers insights into engineered viruses for research and clinical applications.

Focuses on viruses affecting crops and agricultural ecosystems. Discussions include transmission by insects, resistance breeding, and economic impact. This track addresses the development of detection methods and sustainable management practices. Attendees will gain insight into the global relevance of plant virology.

Covers viral infections in livestock, companion animals, and wildlife. Sessions highlight zoonotic potential, vaccination strategies, and disease surveillance in veterinary settings. The track promotes interdisciplinary approaches linking animal and human health. Key topics include foot-and-mouth disease, avian influenza, and rabies.

Examines viruses that affect the central nervous system and cause neurological complications. Topics include viral meningitis, encephalitis, and neuroinflammation. Presentations will cover both acute and chronic outcomes of neurotropic infections. Case studies include herpesviruses, flaviviruses, and enteroviruses.

Focuses on hepatitis viruses (A to E) and their impact on liver function and long-term health. Sessions include updates on diagnosis, treatment, and prevention. The track will cover chronic infection management, antiviral resistance, and liver cancer risk. Discussions emphasize global public health strategies.

Highlights viral infections affecting the respiratory tract, including influenza, RSV, and coronaviruses. This track covers transmission, host response, and clinical management. Experts will present on pandemic preparedness, therapeutic advances, and vaccine development. Pediatric and geriatric considerations will also be addressed.

Covers tools and strategies used to track viral outbreaks, monitor spread, and predict future patterns. Topics include statistical modeling, genomic surveillance, and population-based studies. Sessions highlight how data inform response strategies and resource allocation. Real-time epidemiology will be explored using case examples.

Examines how viral infections can trigger autoimmune responses and long-term health consequences. Topics include post-viral fatigue, Guillain-Barré syndrome, and chronic inflammation. This track highlights the need for longitudinal studies and personalized care approaches. Research into immune dysregulation will be a focus.

Explores computational tools used to analyze viral genomes, mutation patterns, and evolution. Sessions include next-generation sequencing, phylogenetic analysis, and viral metagenomics. This track is ideal for researchers interested in big data applications in virology. Real-world applications in diagnostics and epidemiology will be discussed.

Focuses on ethical considerations in virology research, data sharing, and public communication. Topics include responsible messaging during outbreaks, misinformation challenges, and equity in access to care and vaccines. This track encourages dialogue between scientists, policymakers, and the public to foster trust in scientific processes.